RollingStone Co., Ltd. (KOSDAQ:214610)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,595.00
-60.00 (-2.26%)
At close: Mar 9, 2026
-64.84%
Market Cap 21.74B
Revenue (ttm) 891.68M
Net Income (ttm) -21.07B
Shares Out 8.38M
EPS (ttm) -345.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,976
Average Volume 42,825
Open 2,655.00
Previous Close 2,655.00
Day's Range 2,505.00 - 2,700.00
52-Week Range 2,515.00 - 8,470.00
Beta 0.17
RSI 35.40
Earnings Date Mar 20, 2026

About RollingStone

RollingStone Co., Ltd. provides point-of-care-testing diagnostic systems based on Lab-on-a-Chip technology. The company offers molecular diagnostics devices comprising Veri-Q PREP M16 (G2-16TU) system, a device that include membrane to extract nucleic acid using tube; VERI-Q PCR 316, a device to get the result in a short time using plastic chip; VERI-Q PCR 204 (G2-4), a device to deliver the real-time PCR system; PCR and sample prep kits; Veri-Q PCR 316 PB products; and LabChip, sample tube, and pre-filtering column products. It also provides b... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2009
Employees 48
Stock Exchange KOSDAQ
Ticker Symbol 214610
Full Company Profile

Financial Performance

In 2024, RollingStone's revenue was 4.64 billion, a decrease of -13.55% compared to the previous year's 5.37 billion. Losses were -30.85 billion, 19.7% more than in 2023.

Financial Statements

News

There is no news available yet.